Evidence map›Paper›PMID 40079578›Full record

ArticlemSystems2025

Tas2r105 ameliorates gut inflammation, possibly through influencing the gut microbiota and metabolites.

Xiucai Lan, Liang Ma, Jiaming Ma, Zhipeng Huang, Lingling Liu, Feng Li, Mingbang Wang, Yaomin Hu

Abstract read
In one paragraph

Article in mSystems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. International journal of molecular sciences · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiucai Lan *Department of Geriatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.ORCID 0000-0002-1450-6972
Liang Ma *Department of Radiology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Jiaming MaDepartment of Health-Related Product Assessment, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Zhipeng HuangDepartments of Gastroenterology, First Hospital of Quanzhou affiliated to Fujian Medical University, Quanzhou, China.
Lingling LiuDepartment of Laboratory Animal Science, Shanghai Public Health Clinical Center, Shanghai, China.
Feng LiDepartment of Laboratory Animal Science, Shanghai Public Health Clinical Center, Shanghai, China.ORCID 0000-0003-1291-5315
Mingbang WangDepartment of Neonatology, Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College (Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, Shenzhen, Guangdong, China.ORCID 0000-0002-5989-5377
Yaomin HuDepartment of Geriatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.ORCID 0000-0002-9174-7518

Funding

MOST | National Natural Science Foundation of China (NSFC) 81800488MOST | National Natural Science Foundation of China (NSFC) 81870554, U22A20287
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is an immune-mediated gastrointestinal disorder that significantly impacts the life quality of people worldwide. Genetic factors play crucial roles in the development of IBD. Tas2rs, members of the G protein-coupled receptor (GPCR) superfamily, are known for their roles in bitter taste perception. However, Tas2rs have also been identified in the gut, where they help sense luminal contents and regulate gastrointestinal hormones. Periodontal Tas2r105 has been shown to modulate innate immunity by interacting with metabolites produced by oral bacteria. In this study, we observed increased Tas2r105 in the inflammatory colons induced by dextran sulfate sodium salt (DSS). We also noted that α-gustducin, the α-subunit of GPCRs, is present in the intestine, and that α-gustducin knockout mice exhibit aggravated colitis. Based on these findings, we hypothesize that Tas2r105 may play a role in immune regulation during IBD pathogenesis. To test this hypothesis, we used Tas2r105 knockout (KO) mice in a colitis model. Our results show that the KO mice had significantly shorter colon length, more severe colon inflammation, and greater destruction of the gut barrier compared with control mice. We also observed increased recruitment of macrophages to the lamina propria mucosa in the KO mice. Microbiological analysis revealed a significant increase in

Indexed as

ColitisGastrointestinal MicrobiomeReceptors, G-Protein-CoupledAnimalsColonDextran SulfateDisease Models, AnimalInflammationMaleMiceMice, Inbred C57BLMice, KnockoutDextran SulfateReceptors, G-Protein-Coupledgut microbiotainflammatory bowel diseaseTas2r105

Identifiers

PMID40079578
PMCPMC12013267

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.